Good points but my original point was that the short interest may in fact have nothing to do with futility, which as time goes by seems a smaller possibility. There may be forces at work trying to crush the company to either get the technology, delay it long enough for other technologies to come to market first or just to crush it in order to keep their present business model intact. I think we all often overlook how disruptive DC-Vax could be.
News 
Market Data 
Discover 
AI
